About Hilltop Biosciences
Hilltop Biosciences is a private company based in Norwood, Massachusetts. It has reported $7,794,034 raised in five offerings on Form D since July 2019. Its chief executive is Amanda Drobnis.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 27, 2024 | Dec 12, 2024amended Mar 31, 2025 | $5,303,565of $5.5M target | 73 | $72,652 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 20, 2022 | Jan 3, 2023amended Apr 3, 2023 | $723,524of $1.0M target | 42 | $17,227 | DebtRule 506(b) | Form D/A ↗2 earlier filings |
| Aug 18, 2021 | Aug 27, 2021amended Oct 4, 2021 | $866,345of $1.4M target | 67 | $12,931 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 14, 2020 | May 29, 2020 | $149,746of $450K target | 21 | $7,131 | Securities on exercise, Convertible DebtRule 506(b) | Form D ↗ |
| Jul 2, 2019 | Jul 11, 2019 | $750,854of $1.0M target | 48 | $15,643 | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $7,794,034 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Hilltop Biosciences's Form D filed Mar 31, 2025.
MW
Mark Williams
Executive officer and director
JM
Jessica McLear
Director
AW
Alan Watson
Director
AD
Amanda Drobnis
Chief Executive Officer and President, director
Earlier filings also listed Denise Beavers (director, last listed Apr 2023) and Jill Wittels (director, last listed May 2020).